Zurcher Kantonalbank Zurich Cantonalbank Sells 384 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Zurcher Kantonalbank Zurich Cantonalbank lowered its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 0.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 148,502 shares of the company’s stock after selling 384 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in GE HealthCare Technologies were worth $11,482,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of GEHC. First Command Advisory Services Inc. lifted its stake in GE HealthCare Technologies by 36,900.0% in the third quarter. First Command Advisory Services Inc. now owns 370 shares of the company’s stock valued at $25,000 after buying an additional 369 shares in the last quarter. Pin Oak Investment Advisors Inc. bought a new position in GE HealthCare Technologies in the second quarter valued at approximately $25,000. Legacy Financial Group LLC bought a new position in GE HealthCare Technologies in the third quarter valued at approximately $26,000. OFI Invest Asset Management bought a new stake in shares of GE HealthCare Technologies in the third quarter worth $26,000. Finally, Resources Management Corp CT ADV bought a new stake in shares of GE HealthCare Technologies in the second quarter worth $28,000. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Down 0.6 %

GEHC stock opened at $84.49 on Friday. The company has a debt-to-equity ratio of 1.18, a quick ratio of 0.83 and a current ratio of 1.05. The company’s 50-day simple moving average is $88.74 and its 200 day simple moving average is $77.82. GE HealthCare Technologies Inc. has a 52 week low of $62.35 and a 52 week high of $94.50. The company has a market capitalization of $38.56 billion, a PE ratio of 27.98, a price-to-earnings-growth ratio of 2.96 and a beta of 0.94.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Tuesday, February 6th. The company reported $1.18 EPS for the quarter, beating the consensus estimate of $1.07 by $0.11. GE HealthCare Technologies had a net margin of 8.02% and a return on equity of 25.58%. The business had revenue of $5.20 billion for the quarter, compared to the consensus estimate of $5.09 billion. During the same period in the prior year, the company posted $1.31 earnings per share. GE HealthCare Technologies’s revenue was up 5.3% compared to the same quarter last year. As a group, sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be paid a $0.03 dividend. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $0.12 annualized dividend and a dividend yield of 0.14%. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.97%.

Analysts Set New Price Targets

A number of brokerages have recently commented on GEHC. HSBC began coverage on shares of GE HealthCare Technologies in a research report on Thursday, February 15th. They issued a “buy” rating and a $100.00 price objective on the stock. Mizuho boosted their price objective on shares of GE HealthCare Technologies from $96.00 to $110.00 and gave the stock a “buy” rating in a research report on Thursday, April 11th. Evercore ISI boosted their price objective on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an “outperform” rating in a research report on Thursday, April 4th. UBS Group upgraded shares of GE HealthCare Technologies from a “sell” rating to a “neutral” rating and boosted their target price for the stock from $66.00 to $88.00 in a report on Monday, February 12th. Finally, Morgan Stanley boosted their target price on shares of GE HealthCare Technologies from $74.00 to $86.00 and gave the stock an “equal weight” rating in a report on Monday, February 12th. Four research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $95.09.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.